Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Jul 2026, 16:02
Evidence Synthesis
PharmaID's 38.48% has accelerated, up from -9.85% quarterly.
The company's has also accelerated, up from quarterly. Additionally, PharmaID's INR has accelerated, up from INR daily. The company's shares has decelerated daily.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 38.48 % | -9.85 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -9.85 % | -42.02 | ▲ |
| REVENUE_GROWTH_YOY | 50.7 % | — | - |
| PRICE_CHANGE_PERCENT | 2.643 % | — | - |
| DAILY_VOLUME | 1,541 shares | 17,707 | ▼ |
| CLOSE_PRICE | 31.85 INR | 31.03 | ▲ |